QuickView for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=7C658DC251E2A95B4BEBACE88DA366A7;jsessionid=B0397F548D86A9F2A0056E5154F1AE93;jsessionid=6580419DA1D6096856C9A4CB2A980B1B;jsessionid=A6E1A24146E6496B0ADD470D3B866906;jsessionid=EF932839BED278EC5CAF3842A1B5410E;jsessionid=E992EBF8978F2F93A3B6796A4C571FC8;jsessionid=44082CD00D06FDC58597AD06EBBAEBC0 (gene)

1. Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm.
2. Clinical Evaluation of Cystic Renal Masses With Bosniak Classification by Contrast-Enhanced Ultrasou…
3. Feasibility of Surveillance for Mucinous Cystic Neoplasm of the Pancreas: A Multi-Institutional Retr…
4. Clinicopathological and genetic characteristics of congenital cystic adenomatoid malformation of lun…
5. The added value of contrast-enhanced ultrasound in evaluation of indeterminate small solid renal mas…

There were no clinical trials for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=7C658DC251E2A95B4BEBACE88DA366A7;jsessionid=B0397F548D86A9F2A0056E5154F1AE93;jsessionid=6580419DA1D6096856C9A4CB2A980B1B;jsessionid=A6E1A24146E6496B0ADD470D3B866906;jsessionid=EF932839BED278EC5CAF3842A1B5410E;jsessionid=E992EBF8978F2F93A3B6796A4C571FC8;jsessionid=44082CD00D06FDC58597AD06EBBAEBC0